ASYMCHEM LAB.(TIAN.)H YC1 - Asset Resilience Ratio

Latest as of March 2026: 5.07%

ASYMCHEM LAB.(TIAN.)H YC1 (7K90) has an Asset Resilience Ratio of 5.07% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore 7K90 asset base for the complete picture of this company's asset base.

Liquid Assets

€1.05 Billion

≈ $1.23 Billion USD Cash + Short-term Investments

Total Assets

€20.70 Billion

≈ $24.21 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how ASYMCHEM LAB.(TIAN.)H YC1's Asset Resilience Ratio has changed over time. See 7K90 net asset quality score to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down ASYMCHEM LAB.(TIAN.)H YC1's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 7K90 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€1.05 Billion	5.07%
Total Liquid Assets	€1.05 Billion	5.07%

Asset Resilience Insights

Limited Liquidity: ASYMCHEM LAB.(TIAN.)H YC1 maintains only 5.07% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

ASYMCHEM LAB.(TIAN.)H YC1 Industry Peers by Asset Resilience Ratio

Compare ASYMCHEM LAB.(TIAN.)H YC1's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Royalty Pharma Plc NASDAQ:RPRX	Biotechnology	0.11%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%
Hyundai Bioscience Co. Ltd KQ:048410	Biotechnology	13.57%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	82.25%
Lifecome Biochemistry Co Ltd SHE:002868	Biotechnology	4.69%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%

Annual Asset Resilience Ratio for ASYMCHEM LAB.(TIAN.)H YC1 (2021–2025)

The table below shows the annual Asset Resilience Ratio data for ASYMCHEM LAB.(TIAN.)H YC1.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	5.51%	€1.12 Billion ≈ $1.31 Billion	€20.28 Billion ≈ $23.71 Billion	-2.48pp
2024-12-31	7.98%	€1.54 Billion ≈ $1.80 Billion	€19.29 Billion ≈ $22.55 Billion	-1.66pp
2023-12-31	9.64%	€1.91 Billion ≈ $2.23 Billion	€19.77 Billion ≈ $23.11 Billion	-2.15pp
2022-12-31	11.79%	€2.15 Billion ≈ $2.51 Billion	€18.24 Billion ≈ $21.32 Billion	+9.15pp
2021-12-31	2.65%	€401.20 Million ≈ $469.04 Million	€15.16 Billion ≈ $17.72 Billion	--

pp = percentage points

About ASYMCHEM LAB.(TIAN.)H YC1

F:7K90 Germany Biotechnology

Market Cap

$325.41 Million

€278.35 Million EUR

Market Cap Rank

#14619 Global

#1454 in Germany

Share Price

€10.00

Change (1 day)

-1.96%

52-Week Range

€7.45 - €12.30

All Time High

€13.32